Same Receptor, Opposite Fates: Why S1PR1 Cuts Both Ways in Atherosclerosis
A new review argues that the atherogenic outcome of S1PR1 signalling depends on cell type, ligand presentation and inflammatory context ...
A new review argues that the atherogenic outcome of S1PR1 signalling depends on cell type, ligand presentation and inflammatory context ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.